Linkage analysis with chromosome 15q11-13 markers shows genomic imprinting in familial Angelman syndrome. Issue 12 (December 1992)

• Record Type: Journal Article
• Authors: Meijers-Heijboer, E J; Sandkuijl, L A; Brunner, H G; Smeets, H J; Hoogeboom, A J; Deelen, W H; van Hemel, J O; Nelen, M R; Smeets, D F; Niermeijer, M F
• Is Part Of: Journal of medical genetics. Volume 29:Issue 12(1992)
• Page Start: 853
• Page End: 857
• Publication Date: 1992-12
• Subjects: Medical genetics -- Periodicals; 616.042
• DOI: 10.1136/jmg.29.12.853
• Languages: English
• ISSNs: 1468-6244

Abstract

Abstract : Angelman syndrome (AS) and Prader-Willi syndrome (PWS) have become the classical examples of genomic imprinting in man, as completely different phenotypes are generated by the absence of maternal (AS) or paternal (PWS) contributions to the q11-13 region of chromosome 15 as a result of deletion or uniparental disomy. Apparently, most patients are sporadic cases. The genetic mechanism underlying familial AS has remained enigmatic for a long time. Recently, evidence has been emerging suggesting autosomal dominant inheritance of a detectable or undetectable defect in a gene or genes at 15q11-13, subject to genomic imprinting. The present report describes an unusually large pedigree with segregation of AS through maternal inheritance and apparent asymptomatic transmission through several male ancestors. Deletion and paternal disomy at 15q11-13 were excluded. However, the genetic defect is still located in this region, as we obtained a maximum lod score of 5.40 for linkage to the GABA receptor locus GABRB3 and the anonymous DNA marker D15S10, which have been mapped within or adjacent to the AS critical region at 15q11-13. The size of the pedigree allowed calculation of an odds ratio in favour of genomic imprinting of 9.25 x 10(5). This family illustrates the necessity of extensive pedigree analysis when considering recurrence risks for relatives of AS patients, those without detectable deletion or disomy in particular.